Kellerhals Carrard advised Oxyle, a cleantech spinoff company of ETH Zurich, through successful completion of a $16 million seed financing round. 360 Capital led the capital round in question, with additional support from Axeleo Capital, and returning investors Founderful and SOSV. The technology All proceeds will fund the scaling of Oxyle’s new PFAS destruction technology. […]
Kellerhals Carrard advised Lausanne-based start-up Voltiris in its seed financing round of CHF 4.8M. Investors EquityPitcher Ventures and 3M Ventures co-led the capital round, with further support from the climate tech venture capital fund
Bär & Karrer advised Swiss manufacturer United Grinding Groupon a EUR 800 million acquisition and working capital credit facility regarding the financing of the acquisition of the GF Machining Solutions business unit of Georg Fischer.
Vischer advised Atanis Biotech, a Swiss biotechnology company, to successful completion of an oversubscribed financing round. The financing round The proceeds from this operation will fund the European and North-American marketing campaigns for Atanis’s “
Kellerhals Carrard advised Insurteam, a Swiss travel insurance company, in a CHF 700k seed financing round. The seed capital round in question has been led by Spicehaus Partners, with support from Insurangels Suisse and SICTIC
Walder Wyss advised UBS Switzerland, which served as the mandated lead arranger and underwriter, financing Polygena’s acquisition of Kubo Tech and its subsidiaries. The companies involved Polygena is a Swiss industrial group part of
Homburger acted as legal advisor to UBS Switzerland in its role as mandated lead arranger, sole underwriter, bookrunner, agent, security agent, and original lender for the financing of United Grinding Group’s acquisition of GF
Advestra has acted as Swiss legal counsel to the initial purchasers and lenders in connection with the financing of Bain Capital’s acquisition of SO.MA.CI.S. and the subsequent acquisition of AT&
BGPartner has advised OrbiMed and Novo Holdings on Swiss legal matters related to the USD 200 million Series A financing of Windward Bio Group, a Swiss-based clinical-stage drug development company, advised by Homburger. The financing round
Baker McKenzie Switzerland advised R&S Group, a manufacturer of electrical infrastructure, in connection with its new CHF 160 million term loan (TL) and CHF 30 million revolving credit facilities (RCF) agreement with UBS Switzerland, advised
